Therapeutic effects of human amniotic epithelial cell transplantation on double-transgenic mice co-expressing APPswe and PS1ΔE9-deleted genes by ShouRu Xue et al.
SCIENCE CHINA 
Life Sciences 
© The Author(s) 2012. This article is published with open access at Springerlink.com life.scichina.com   www.springer.com/scp 
                  
*Corresponding author (email: huiguozhen@163.com; guolihe@cellstar.com.cn) 
• RESEARCH  PAPER • February 2012  Vol.55  No.2: 132–140 
 doi: 10.1007/s11427-012-4283-1 
Therapeutic effects of human amniotic epithelial cell transplanta-
tion on double-transgenic mice co-expressing APPswe and 
PS1E9-deleted genes 
XUE ShouRu1, CHEN ChongFang1, DONG WanLi1, HUI GuoZhen2*, 
LIU TianJun3 & GUO LiHe3* 
1Department of Neurology, First Affiliated Hospital of Soochow University, Suzhou 215006, China; 
2Department of Neurosurgery, First Affiliated Hospital of Soochow University, Suzhou 215006, China; 
3Institute of Biochemistry and Cell Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, 
Shanghai 200031, China 
Received June 23, 2011; accepted November 27, 2011 
 
Human amniotic epithelial cells (HAECs), which exhibit characteristics of embryonic and pluripotent stem cells, could be uti-
lized for cell therapy without legal or ethical problems. Double-transgenic (TG) mice (n=20) and wild-type (WT) mice (n=20) 
were randomly assigned to two groups, respectively. The transplantation group was treated with HAECs and the control group 
with PBS. A six-radial arm water maze was used to assess spatial memory. Immunofluorescence was utilized to track HAEC 
survival. Immunohistochemistry was used to determine octamer-binding protein 4 (oct-4) and nanog expression in the HAECs. 
High-performance liquid chromatography (HPLC) was used to measure acetylcholine levels in the hippocampus. The density 
of cholinergic neurons in the basal forebrain and nerve fibers in the hippocampus was measured following acetylcholinesterase 
staining. Results showed that transplanted HAECs survived for at least eight weeks and migrated to the third ventricle without 
immune rejection. Graft HAECs also expressed the specific stem cell markers oct-4 and nanog. Compared with the control 
group, HAEC transplantation significantly ameliorated spatial memory deficits in TG mice, as well as increased acetylcholine 
levels and the number of hippocampal cholinergic neurites. Intracerebroventricular HAEC transplantation improved spatial 
memory in double-TG mice, and results suggested that increased acetylcholine levels in the hippocampus, released by surviv-
ing cholinergic neurites, were responsible for this improvement. 
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Alzheimer’s disease (AD) is a neurodegenerative disorder 
characterized by deposits of extracellular -amyloid (A) 
plaques, intracellular neurofibrillary tangles, and deficits in 
the cholinergic system [1]. The amyloid cascade and cho-
linergic hypotheses have been previously proposed for AD 
[2,3]. Transgenic mouse models of Alzheimer’s disease 
have become indispensable tools for studying plaque for-
mation, cholinergic deficits, and cognitive decline. Mutant 
mouse models have focused on two genes known to cause 
AD, namely amyloid precursor protein (APP) and presenilin 
1 (PS1). Age-related amyloid deposition has been shown in 
the hippocampus and neocortex of APP/PS1 double-trans-     
genic mice at 6–7 months, which is earlier than with single 
APP transgenic mice [4]. Previous results have shown that 
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cholinergic nerve terminal degeneration precedes A plaque 
deposition, as well as significantly less cholinergic nerve 
terminal varicosities in 4-month-old APP transgenic mice 
[5]. Cholinergic neurotransmission plays an important role 
in learning and memory, and the cholinergic hypothesis is 
supported by the fact that several cholinesterase inhibitors 
(donepezil, rivastigmine, and galantamine) are currently 
marketed for AD treatment [6]. AchE inhibitors serve as a 
symptomatic therapy for AD, and a more restorative ap-
proach to AD therapy involves replacement of degenerating 
cholinergic neurons and nerve fibers through various possi-
ble cell sources [7]. While some success has been gained 
with fetal ventral mesencephalic (FVM) tissue transplants, 
the rapidly advancing stem cell field provides attractive 
alternative options to circumvent most ethical and practical 
problems inherent in trials using FVM tissue. Specifically, 
embryonic stem cells and induced pluripotent stem cells 
provide the most promise. However, ethical and political 
issues have limited the use of fetal stem cells, and cell re-
sources and rejection issues have complicated the use of 
adult stem cells. 
AD pathogenesis is complicated and the etiology of AD 
remains unknown. Treatment with traditional cholinesterase 
inhibitors has not resulted in great progress. However, it has 
been postulated that stem cell transplantation could provide 
novel methods for treating the disease [8]. In human beings, 
these therapies could create legal or ethical problems. Hu-
man amniotic epithelial cells (HAECs) are formed from 
epiblasts at eight days after fertilization, and these cells 
constitute the inner layer of the amnion, which suggests that 
they could maintain plasticity of pre-gastrulation embryo 
cells. HAECs lack major histocompatibility complex (MHC) 
antigen; therefore, there is a low risk for tissue rejection 
following transplantation [9]. HAECs secrete biologically 
active neurotrophins, such as brain-derived neurotrophic 
factor (BDNF), neurotrophin-3, insulin-like growth factors, 
epidermal growth factor, prostaglandin E2, laminin, nerve 
growth factor (NGF), and transforming growth factor-alpha 
[10,11], some of which exhibit trophic activities on dopa-
minergic neurons following transplantation[12]. In addition, 
HAECs do not express telomerase and are non-tumorigenic. 
Based on these biological characteristics, HAECs are suita-
ble for transplantation. Most importantly, HAECs are de-
rived from term placenta after live birth, which is a useful 
and noncontroversial source of stem cells for cell transplan-
tation and regenerative medicine [13]. 
Nevertheless, the neuroprotective effects of intracere-
broventricular HAEC transplantation on AD remain poorly 
understood. The present study transplanted EGFP-trans-     
fected HAECs into the lateral ventricle of double transgenic 
mice that co-expressed mutant APPswe and PS1ΔE9 genes 
to determine if transplantation improved cognitive func-
tions.  
1  Materials and methods 
1.1  Experimental animals and groups 
APPswe/PS1E9 founder mice were obtained from Nanjing 
Institute of Experimental Model Animal and were bred in a 
heterozygote colony by pairing transgenic mice with normal 
wild-type (WT) littermates (C57BL6/J). The transgenic 
mice expressed a mutant form of human FAD variant of 
PS1E9 (deletion of exon 9) and a chimeric mouse/human 
amyloid precursor protein APPswe (mouse APP695 har-
boring a human A domain and mutations K595N and 
M596L linked to Swedish FAD kindred). The mice were 
allowed free access to food and water and were housed in a 
12 h dark-light cycle. All experiments were performed dur-
ing the light phase of the circadian cycle. Mice were geno-
typed using previously described methods [14], which were 
confirmed by slot blots shortly after weaning and at nec-
ropsy. Animal care and experimental procedures were con-
ducted according to Chinese national guidelines for animal 
care. 
The PS1E9 transgenic mice and mutant APPswe trans-
genic mice were crossbred to generate hemizygous offspring 
with four possible genotypes: nontransgenic (wild-type); 
PS1E9 transgenic; APPswe transgenic and double-trans-      
genic APPswe+PS1ΔE9. Double-transgenic and WT mice 
were randomly assigned to two groups. The transplantation 
group was treated with EGFP-transfected HAECs, and the 
control group with an equal amount of PBS. 
1.2  Tissue staining 
Eight-month-old, female mice were anesthetized with pen-
tobarbital (100 mg kg1 intraperitoneal) and were transcar-
dially perfused with 25 mL normal (0.9%) saline. The 
brains were rapidly removed and fixed in freshly depoly-
merized 4% paraformaldehyde for 24 h. The right hemi-
spheres were rapidly dissected into hippocampus+cortex 
regions on a cold stage, followed by freezing on dry ice and 
storage at 70°C. Fixed, cryoprotected hemispheres (left) 
were frozen and sectioned to 25-m thick sections in a hor-
izontal plane using a sliding microtome. The sections were 
then stored at 4°C in phosphate-buffered saline for im-
munocytochemistry and histology. 
Sections were incubated with the primary antibody for 18 h 
at 4°C, and antisera specific for A peptides ending at resi-
due 42 (A42) were obtained from Quality Controlled Bio-
chemical (Hopkinton, USA), then incubated in biotinylated 
secondary antibody (120 min), followed by avi-
din-biotin-peroxidase complex using the Vectastain Elite 
kit. 
Congo red and acid-silver methenamine histology was 
performed on sections mounted on slides. The sections were 
air-dried for a minimum of 12 h, then rehydrated for ap-
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proximately 30 s prior to staining. For the Congo red stain-
ing, the hydrated sections were incubated in an alkaline al-
coholic saturated sodium chloride solution for 20 min, then 
incubated in 0.2% Congo red in alkaline alcoholic saturated 
sodium chloride solution for 30 min. For the acid-silver 
methenamine staining, sections were stained for 15 min in a 
1% solution and quickly rinsed with water. For both stain-
ings, sections were rinsed in three rapid changes of 100% 
ethanol, cleared through three changes of xylene, and then 
coverslipped with DPX (Sigma, USA). 
One week after behavioral analysis, samples were sub-
jected to acetylcholinesterase staining. The sections were 
incubated (5 mg acetylcholine iodide, pH 6.0; 6.5 mL ace-
tate buffer, 0.5 mL of 0.1 mol L1 sodium citrate; 0.5 mL of 
0.03 mol L1 copper sulfate, 0.2 mL 0.005 mol L1 potas-
sium fenicyanide, 1 mL deionized water) for 2 h, then 
rinsed through five changes of acetate buffer, cleared 
through 1% ammonia solution for 1 min, immersed in sul-
fide, then washed five times with 1% sodium nitrate. 
1.3  Behavioral analysis  
A total of 20 double-transgenic and 20 WT female mice 
were chosen for behavioral testing. A water maze with six 
radial arms was made from a black-painted steel pool with a 
one-meter diameter, which was filled with 20°C water. The 
pool contained a maze that consisted of six arms that radi-
ated from the central arena. One of the arms contained a 
submerged escape platform. The testing room contained 
spatial clues consisting of posters and objects of different 
shapes that hung on the walls and ceiling. Prior to testing, 
the mice were pre-trained for 5 d. On the first day, the mice 
were placed in the water maze, and only two of the arms 
were open. The mice swam from one arm through the cen-
tral arena to the escape platform on the other side of the 
pool. If the swimming time exceeded 120 s, the mice were 
gently guided to the escape platform. The mice were al-
lowed to remain on the escape platform for 30 s before be-
ing returned to their cages. The mice performed five trials at 
10-min intervals, and the trial complexity increased during 
the following four days of pre-training by opening a new 
arm each day. Memory testing was performed in the after-
noon over 10 consecutive days. The mice were subjected to 
five trials, with 10-min intervals, each day and all arms 
were open. The mice were placed in a randomly chosen arm 
at each trial. The escape platform location was changed 
each day and remained at that location for the duration of 
the testing day. The platform location order was random, 
but all six arms were used as a target over a six-day testing 
period. An error was scored if a mouse entered more than 
halfway into an arm with no escape platform. The number 
of errors, search sequence, and time needed to locate the 
escape platform were noted for each trial. The mice were 
tested before and after transplantation. 
1.4  HAECs cultures 
HAEC cultures were prepared as previously described [15]. 
Briefly, the human amniotic membrane was mechanically 
peeled from the placenta chorion, which was obtained from 
an uncomplicated, elective, caesarean section with informed 
consent from each donor patient. The HAEC layer was 
thoroughly scraped out from underlying tissues, such as 
spongy and fibroblast layers. The HAEC layer was then 
treated three times with 0.125% trypsin for 20 min each to 
obtain dissociated HAECs. The cells were cultured in 
RPMI-1640 medium containing 10% fetal calf serum at 
37°C in a 95% air/5% CO2 humidified atmosphere. The 
culture medium was replaced every three days. The HAECs 
were transfected with EGFP as previously described [16]. 
1.5  Transplantation 
Transgenic and WT mice were injected into the lateral ven-
tricle with HAECs using a 10 μL Hamilton microsyringe 
(Hamilton) fitted with a steel cannula according to the fol-
lowing coordinates: AP 0.8 mm, ML 1.3 mm, and DV 
4.8 mm. A total of 8 μL HAECs (3×104 in 2 L) were in-
jected into each mouse. Following completion of injections, 
the cannula was left in situ for 5 min before being slowly 
retracted to minimize cell diffusion up the needle track. 
Mice from the control and model group received 2 L basal 
medium. All experimental animals were immunosuppressed 
with FK-506 (Huijia Pharmaceutical, Beijing, China, 5 mg 
kg1, intraperitoneal, daily), starting at the day of transplan-
tation surgery. 
1.6  Immunofluorescence  
At eight weeks after transplantation, the mice were sacri-
ficed by CO2. The brain sections were incubated overnight 
at 4°C with primary antibodies against octamer-binding 
protein 4 (oct-4) (1:2000; Chemicon International, Temec-
ula, CA, USA) and nanog (1:2000; Sigma). The sections 
were then incubated for 1 h at room temperature with roda-
mine-conjugated secondary antibodies. After washing, cov-
er slips were mounted onto the slides and digital images 
were recorded using an Olympus microscope. 
1.7  High performance liquid chromatography assay 
for acetylcholine in hippocampus and cortex 
To measure acetylcholine levels, a Metachem column (250 
mm×4.6 mm, 18.5 m) was used in combination with an 
electrochemical detector (500 mV (Ag/AgCl)). The mobile 
phase consisted of 50 mg L1 disodium EDTA, 4.1 g L1 
sodium acetate, 140 mg L1 sodium octane-sulfonic acid, 
140 mg L1 sodium octane-sulfonic acid, and 1.8% v/v 
methanol. The flow rate was 1.3 mL min1, and the detec-
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tion limit was 0.5 fmol per sample. 
1.8  Statistical analysis 
Two-way ANOVA with the post-hoc Scheffe’s test was 
utilized to compare escape latency and acetylcholine levels 
between groups. The significance level was set to P<0.05. 
SPSS 16.0 was used to perform statistical analysis. 
2  Results 
2.1  -amyloid deposition in double-transgenic mice 
A diffuse orange-red amyloid deposition was visible fol-
lowing the Congo red staining in the hippocampus and 
frontal cortex of the 8-month-old double-transgenic mice, 
but not in the WT mice, as showed in Figure 1. Neurofibril-
lary tangles, which were stained by acid-silver methenamine, 
were not observed in either the transgenic or the WT mice, 
as showed in Figure 2. These results demonstrated that 
8-month-old double-transgenic mice co-expressing APPswe 
and PS1E9 genes exhibited obvious amyloid plaques in 
the hippocampus and frontal cortex. 
2.2  HAEC characteristics and identification of EGFP- 
labeled cells 
Under a light microscope, HAECs appeared round, oval, or 
triangular in shape, with a large nucleus and fat drops in the 
cytoplasm, as previously described [15]. Under a fluores-
cence microscope, EGFP-labeled HAECs exhibited blue 





Figure 1  Distribution of -amyloid deposition stained by Congo red in double TG and WT mice after HAECs transplantation. Sections from frontal cortex 
and hippocampus in double TG mice (A and C) and WT mice (B and D) are compared. The orange-red amyloid deposition was found in double TG mice  
aged 8 months, and not found in WT mice aged 8 months. 
 
Figure 2  Acid-silver methenamine staining in double TG (A) and WT (B) mice. No neurofibrillary tangles were found in them aged 8 months. 
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2.3  HAEC survival and expression following trans-
plantation  
At eight weeks after transplantation, surviving HAECs were 
observed in the lateral ventricle and third ventricle, and the 
cells expressed oct-4 and nanog. The surviving HAECs 
were not overgrown, which indicated that HAEC transplan-
tation was safe for the AD mice. Oct-4 and nanog-positive 
cells were not detected in the control mice, as shown in 
Figure 3A and B. 
2.4  Radial water maze testing 
Body weight differences were not significant between the 
double-transgenic mice (36.2±1.3, n=20) and the WT mice 
(37.6±1.2, n=20, P>0.05). The numbers of errors per trial 
decreased according to trial number in both experimental 
groups. At 8 months of age, learning curves of transgenic 
mice were different than the WT mice. A Wilcoxon-Mann-      
Whitney test revealed differences between individual trials 
in 8-month-old WT and transgenic mice; trials 4 and 5 were 
significantly different (trial 1, P>0.92; trial 2, P>0.09; trial 3, 
P>0.06; trial 4, P<0.03; trial 5, P<0.02). 
At 8 weeks after transplantation, learning curves of WT 
and double-transgenic mice with HAEC transplantation 
varied from control mice. A Wilcoxon-Mann-Whitney test 
between individual trials revealed significant differences in 
the 8-month-old transgenic and WT groups in trials 3–5 
(trials 1–2, P>0.05; trials 3–5, P<0.05, respectively), as 
shown in Figure 4. At this age, the WT mice systematically 
committed fewer errors than the transgenic mice, whereas 
behavior of transgenic mice was not altered. Both WT and 
transgenic mice learned the escape platform position in the 
water maze test on the day of testing. Double-transgenic 
mice and WT mice with HAECs transplantation were more 
efficient than controls in locating the escape platform. 
2.5  Acetylcholine levels in the hippocampus and 
frontal cortex following HAEC transplantation 
Within the control group, acetylcholine levels were signifi-
cantly less in the transgenic mice than in the WT mice. 
Compared to double-transgenic mice injected with PBS, 








Figure 3  A, The survival of transplanted grafts. Eight weeks after transplantation, HAECs were alive, not overgrown and found in the lateral ventricle (a) 
and the third ventricle (b). The control group (c) has not found the survived cells. B, The expression of transplanted grafts. Eight weeks after transplantation,  
HAECs expressed oct-4 (b) and nanog (d) in transplantation mice. No oct-4 or nanog-positive cells were found in controls (a and c). 
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Figure 4  Spatial memory testing in the water maze. A, Number of total 
errors obtained in 8 months old mice in double TG and WT mice before 
transplantation on the five trials. Each point represents the average number 
of errors per trial over 10 days of testing. B, Same as A at 8 months in TG 
mice in transplantation and controls. C, Same as A at 8 months in WT mice  
in transplantation and controls. Error bars represent in all cases the SEM. 
Table 1  Hippocampal acetylcholine concentrations of the different 
groups (each group n=10)a) 
Group Peak area Concentration (g mL1) 
TG transplant 12.6 0.112▲ 
TG control 9.18 0.090★ 
WT transplant 19.1 0.169△ 
WT control 12.7 0.113* 
a) Compared with TG control, *, P<0.01; △, P<0.01; ▲, P=0.01; 
compared with WT control, △, P>0.05; ▲, P>0.05; ★, P<0.01. 
 
 
and double-transgenic mice injected with HAECs were sig-
nificantly increased, as shown in Table 1. 
2.6  Cholinergic neurons in the basal forebrain and 
nerve fibers in the hippocampus, as detected by AChAT 
Compared with control transgenic mice, the number of cho-
linergic neurons significantly increased in the basal fore-
brain of TG mice injected with HAECs ((37.7±2.7) m2 vs. 
(24.4±2.8) m2, P<0.01), but not in the WT mice. The size 
of cholinergic neurons in the WT mice injected with 
HAECs significantly increased compared with control WT 
mice ((53.1±4.2) m2 vs. (44.2±3.8) m2, P<0.05), as 
shown in Figure 5. 
Hippocampal cholinergic nerve fibers in the double- 
transgenic mice were irregularly arranged. The number of 
hippocampal cholinergic nerve fibers significantly increased 
in the transgenic mice injected with HAECs compared with 




Figure 5  The numbers of cholinergic neurons in basal forebrain stained by AChAT among the four groups were compared. A, WT transplantation. B, TG 
transplantation. C, WT control. D, TG control. 
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Figure 6  Hippocampal cholinergic nerve fibers stained by AChAT among the four groups were compared. A, WT transplantation. B, TG transplantation. 
C, WT control. D, TG control. 
 
133.8) m2, P<0.01). The size of hippocampal choliner-
gic nerve fibers in the WT mice injected with HAECs was 
significantly greater than in control WT mice ((762.1± 
194.2) m2 vs. (689.2±173.8) m2, P<0.05), as shown in 
Figure 6. 
3  Discussion 
Several attempts have been made to transplant stem cells 
into the brain to treat a variety of neurodegenerative disor-
ders. Recent studies using implanted cells, including adult 
stem cells and fetal transplants, provide promising results in 
experimental models of neurodegenerative disease, such as 
Alzheimer’s disease [17,18]. HAECs express surface mark-
ers typically present on embryonic stem and germ cells. In 
addition, under certain culture conditions, HAECs form 
spheroid structures that retain stem cell characteristics [19], 
evidenced by the fact that HAECs express the pluripotent 
stem cell-specific transcription factors oct-4, nanog, 
SSEA-4, TRA 1-60, and TRA 1-81 [20]. These results sug-
gest that HAECs exhibit putative multipotential differentia-
tion towards neurons, astrocytes, and oligodendrocytes [21]. 
Furthermore, HAECs synthesize and release BDNF, glial 
cell line-derived neurotrophic factor (GDNF), neurotro-
phin-3, NGF, and other factors [21,22]. BDNF has been 
shown to exert trophic effects on cholinergic neurons [23], 
and GDNF and NGF provide protection to degenerating 
cholinergic neurons in AD, as well as promote regeneration 
of the hippocampal cholinergic system [24]. Therefore, 
HAEC transplantation could serve as a useful and noncon-
troversial source of stem cells [25]. Our previous study 
showed that some EGFP-labeled HAECs survive and mi-
grate out of the injection site following transplantation [16]. 
In addition, HAEC transplantation has been shown to ame-
liorate impaired functions in a dopamine-degenerated 
mouse model [26].  
In the present study, intracerebroventricular transplanta-
tion of HAECs in transgenic and WT mice resulted in im-
provement of spatial memory deficits compared to control 
mice. Transplanted HAECs survived for at least eight weeks 
in the transgenic and WT mice, and the numbers of errors 
were less in transplantation mice than control mice. HAECs 
also prevented decreased hippocampal acetylcholine levels 
in the transplantation mice. AChAT staining revealed an 
increase in the number of cholinergic neurons in the basal 
forebrain, as well as nerve fibers in the hippocampus, in the 
transplantation mice compared with the PBS group. The 
double-transgenic mice exhibited spatial memory deficits, 
which suggested an effective inhibitory effect of Aβ on ac-
etylcholine release. It was assumed that improved spatial 
memory in the transplantation group correlated with en-
hanced levels of nutritional factors, such as NGF, BDNF, 
and GDNF [21–24]. Neurotrophins protect and nourish de-
generating neurons, as well as induce HAECs to differenti-
ate into cholinergic neurons. Cognitive symptoms of AD do 
not correlate with amyloid load. However, the symptoms do 
significantly correlate with a decreased number of hippo-
campal cholinergic neurons and nerve fibers. It has, there-
fore, been suggested that the increased acetylcholine secre-
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tion by cholinergic neurons could improve cognitive de-
clines of the disease [1,8]. Results have shown that the de-
gree of dementia positively correlates to the number of de-
generated cholinergic neurons [27]. The degree of learning 
and memory handicaps positively correlates with the num-
ber of cholinergic neurons and ChAT activity [28]. Previous 
results have also shown that cholinergic nerve terminal de-
generation precedes A plaque deposition [5]. Therefore, 
increased acetylcholine levels in the hippocampus, as a re-
sult of a greater number of surviving cholinergic neurites, is 
likely involved in this improvement. These results support-
ed the hypothesis that HAECs could serve as useful cell 
resource for cell therapy in degenerative disease. 
Results from the present study revealed -amyloid depo-
sition in the hippocampus and frontal cortex in the dou-
ble-transgenic mice co-expressing APPswe and PS1ΔE9 
genes at 8 months of age. These results were in accordance 
with previous results [29]. In addition to detection of amy-
loid plaques, learning and memory was analyzed in dou-
ble-transgenic and WT mice using the six-arm radial water 
maze. The water maze test is dependent on hippocampal 
functions and is generally accepted as a sensitive test for 
short-term episodic memory. Visiting the platform location 
from the previous day reflects long-term reference memory 
[4]. Results demonstrated that performance of the 8-month-      
old, double-transgenic mice was affected compared to WT 
controls; the double-transgenic mice revisited the arm with 
the escape platform from the previous testing day more of-
ten. However, the double-transgenic mice made more errors 
than the WT controls. These results were similar to results 
from earlier studies using other types of behavioral tests that 
indicated deficits in spatial learning and memory in the 
APPswe/PS1E9 mice [30]. The present results suggested 
that APPswe/PS1E9 mice are suitable for testing possible 
replacement therapeutics. 
Immunological rejection is a common problem associat-
ed with substitutive therapy with stem cells. In the present 
study, transplanted HAECs survived for at least eight weeks, 
which could correlate with a weak brain immune response 
to HAECs. Studies have shown that HAECs express major 
histocompatibility complex (MHC) I, but lack MHC II [19], 
resulting in a relatively weak immune response. 
In summary, following transplantation into the lateral 
ventricle, HAECs survived for 8 weeks without inducing an 
immune rejection. HAEC transplantation increased hippo-
campal acetylcholine levels, improved spatial memory 
functions, and ameliorated damage to the surviving cholin-
ergic neurons. These results provide a theoretical basis for 
clinical application of HAECs. The therapeutic future of 
HAECs as a reliable and efficient therapeutic tool for AD, 
as well other degenerative diseases, depends on methodo-
logical development of isolation, proliferation, storage, and 
easy access of a highly homogeneous cell population. 
However, this approach could provide promise and a novel 
method for AD treatment. 
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